Maintenance Therapy Considerations for Advanced Ovarian Cancer

Insights from 2023 ESGO Annual Meeting
B

ESGO 2023 Insights: "CA125 Kinetics - KELIM to Help Select Ovarian Cancer Patients for Treatment With Bevacizumab and Potentially PARPi"

By Insights from 2023 ESGO Annual Meeting FEATURING Benoit You
By Insights from 2023 ESGO Annual Meeting FEATURING Benoit You
181 views
October 11, 2023
Comments 0
Login to view comments. Click here to Login
09:42

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer

Erin Crane

216 views
08:37

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer: D…

Fred Hutchinson Cancer Center

K. Banda

220 views
06:50

Year in Review: Ovarian Cancer

Fengting Yan

442 views
16:44

Is There a Role for Predictive Biomarker in Gynecological Malignancy…

Insights from 2023 ESGO Annual Meeting

V. Heinzelmann-Schwarz

135 views
17:06

Genetic Testing in Early and Recurrent Ovarian Cancer

2023 Evolution Conference

J. Barr

159 views
16:52

PARP Inhibitors in GYN Cancers

2023 Evolution Conference

T. Berman

266 views
28:11

Ovarian Cancer: Setting a New Standard of Care

OncoAlert

M. Raza Mirza

1.1K views
26:18

Fred Hutchinson Cancer Center Ovarian Cancer Treatment Updates

Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

K. Banda

304 views